| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/22/1998 | EP0836380A1 Fgf9 as a specific ligand for fgfr3 |
| 04/22/1998 | EP0686154B1 Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | EP0515460B1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/22/1998 | EP0429480B1 Natriuretic hormone |
| 04/22/1998 | CN1179327A Medicine for treating woman's dysmenorrhea and preparing process thereof |
| 04/22/1998 | CN1179322A Powder for removing infantile malnutrition |
| 04/22/1998 | CN1179321A Epilepsy recovering pill and preparing process thereof |
| 04/22/1998 | CN1179315A Medicine for treating hyperosteogeny disease and preparing process thereof |
| 04/22/1998 | CN1179311A Chinese patent medicine for treating various autoimmune diseases and preparing process thereof |
| 04/22/1998 | CN1179309A Use spleen of animal for treating disease |
| 04/22/1998 | CN1179269A Health microbial frozen drink |
| 04/22/1998 | CN1038106C Method for producing acupuncture point plaster for treatment of cough |
| 04/22/1998 | CN1038105C Method for making apoplexy plaster |
| 04/22/1998 | CN1038104C Process for extracting therapeutic components from Chinese medical stone |
| 04/21/1998 | US5741894 Heating crosslinked and uncrosslinked hemoglobin in presence of nonstoichiometric amounts of oxygen resulting in precipitation of uncrosslinked hemoglobin |
| 04/21/1998 | US5741692 Used in compositions for selectively and completely disinserting vitreous body from neural retina of an eye |
| 04/21/1998 | US5741685 Parenchymal cells packaged in immunoprotective tissue for implantation |
| 04/21/1998 | US5741494 Immunopotentiative and infection-protective agent containing bacillus and egg white |
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/16/1998 | WO1998015616A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015575A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | DE3891033C2 Method for re-endothelialising denuded vascular lining |
| 04/16/1998 | CA2269090A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2267067A1 Promoter for smooth muscle cell expression |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835658A2 Enhancing and stabilizing agent of the activity of bifidus factor |
| 04/15/1998 | EP0835321A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 04/15/1998 | EP0835319A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835309A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 04/15/1998 | EP0835137A1 Encapsulated cells producing viral particles |
| 04/15/1998 | EP0835124A1 Serum preparations for inhibiting retroviruses and tumor growth |
| 04/15/1998 | EP0835108A1 Use of lamellarin-class alkaloids in methods of treatment |
| 04/15/1998 | CN1179107A Dried blood factor composition comprising trehalose |
| 04/15/1998 | CN1178833A Bacillus licheniformis bacterial strain and its micro ecological preparation |
| 04/15/1998 | CN1178708A Health mask for curing and preventing typhoid |
| 04/15/1998 | CN1178698A Naoxinkang preparation and its producing technology |
| 04/15/1998 | CN1178697A Chinese drug for curing rheumatism and its producing technology |
| 04/15/1998 | CN1178683A Eyesight improving liquid for curing shortsightedness by fumigation |
| 04/15/1998 | CN1178682A Chinese drug Mingmudan pill for improving eyesight and its producing method |
| 04/15/1998 | CN1178677A Luteotropic preparation for parturient women and its producing technology |
| 04/14/1998 | US5739288 Fibrin sealant compositions |
| 04/14/1998 | US5739033 Aqueous density gradient composition for isolating and purifying pancreatic islets from acinar cells |
| 04/14/1998 | US5739026 DNA expression systems based on alphaviruses |
| 04/14/1998 | US5738876 Method of solution overcoating with gelling polymer |
| 04/14/1998 | US5738792 Method for separation of matter from suspension |
| 04/14/1998 | CA1339814C Pharmaceutical formulations |
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014222A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | WO1998014197A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | WO1998014177A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | WO1998014058A1 Cryopreservation of human adult and fetal pancreatic cells and human platelets |
| 04/09/1998 | WO1997045550A3 Mini-adenoviral vector |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267340A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267111A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/08/1998 | EP0834556A1 Methods for culturing cells |
| 04/08/1998 | EP0833935A1 Cell line producing analgesic compounds for treating pain |
| 04/08/1998 | EP0833934A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/08/1998 | EP0833923A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 04/08/1998 | EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 04/08/1998 | EP0833896A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 04/08/1998 | EP0833893A1 Isolation of mammalian hematopoietic stem cells |
| 04/08/1998 | EP0833657A1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 04/08/1998 | EP0833649A1 Methods of preventing or treating allergies |
| 04/08/1998 | EP0833644A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0833607A1 Tar-containing composition and pharmaceutical and cosmetic preparation containing the same |
| 04/08/1998 | EP0711170B1 T-lymphocyte-containing pharmaceutical composition for treating infections |
| 04/08/1998 | CN1178109A Medicine for burn and scald |
| 04/08/1998 | CN1178092A Touring pillow cup with multifunctions of medicinal magnet health-care refreshing and hypnotizing |
| 04/08/1998 | CN1037967C Novel intermediate and its use of preparation of acid |
| 04/08/1998 | CN1037928C Preparation of nutriment using tortoise and/or soft-shelled turtle |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | US5736392 Composition for transfecting eukaryotic cell comprising peptide-nucleic acid complex and cationic lipid capable of aggregating complex |
| 04/07/1998 | US5736372 Artificial matrices for growth of bone |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | US5736157 Parenterally administering a therapeutically effective amount of a lipid acceptor |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013475A1 Methods for culturing cells |
| 04/02/1998 | WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | WO1998013068A1 Medicinal prophylactic 'trisan' |